{"id":107596,"date":"2020-02-25T09:08:54","date_gmt":"2020-02-25T08:08:54","guid":{"rendered":"https:\/\/sdk.mk\/?p=107596"},"modified":"2020-02-25T09:08:54","modified_gmt":"2020-02-25T08:08:54","slug":"ju-njoftojme-me-semundjet-e-rralla-leukemia-kronike-mieloide","status":"publish","type":"post","link":"https:\/\/sdk.mk\/index.php\/uncategorized-sq\/ju-njoftojme-me-semundjet-e-rralla-leukemia-kronike-mieloide\/","title":{"rendered":"JU NJOFTOJM\u00cb ME S\u00cbMUNDJET E RRALLA: LEUKEMIA KRONIKE MIELOIDE"},"content":{"rendered":"<div class=\"f52428582a4b906b2d2e2a7d733c7d27\" data-index=\"7\" style=\"float: none; margin:10px 0 10px 0; text-align:center;\">\n<!-- MSP Ads Asynchronous JS Tag - Generated with Revive Adserver v5.4.1 -->\r\n<ins data-revive-zoneid=\"167\" data-revive-id=\"060fdb01f6430ec164d3519234aa4967\"><\/ins>\r\n<script async src=\"\/\/panel.ads.com.mk\/www\/delivery\/asyncjs.php\"><\/script>\n<\/div>\n<p><a href=\"https:\/\/www.youtube.com\/watch?v=zuixtMFKf_E&amp;list=PLPGcigDEy-qj0I1um2ByEqy4a1IdVRjzf&amp;index=26&amp;t=0s\" target=\"_blank\" rel=\"noopener noreferrer\"><em><strong>LEUCEMIA KRONIKE MIELOIDE<\/strong><\/em><\/a><\/p>\n<p>MKB S 92.1<br \/>\nChronic myeloid leukaemia (CML)<br \/>\nLeukemia kronike mieloide (CML) \u00ebsht\u00eb s\u00ebmundje e ngadalt\u00eb progresive e palc\u00ebs s\u00eb kock\u00ebs dhe gjakut, ku nj\u00eb num\u00ebr i madh i qelizave stematike t\u00eb gjakut (blaste) kalojn\u00eb tek qelizat e bardha t\u00eb gjakut, t\u00eb quajtura granulocite, t\u00eb cilat jan\u00eb jonormale ose leucemike. CML shfaqet tek t\u00eb gjitha grupmoshat, por m\u00eb shpesh tek mosha e mesme dhe tek t\u00eb moshuarit.<\/p>\n<p>Kjo s\u00ebmundje p\u00ebrb\u00ebn 15-20% t\u00eb t\u00eb gjitha rasteve t\u00eb leukemis\u00eb. Incidencia \u00ebsht\u00eb 1-2 n\u00eb 100.000 njer\u00ebz, ku m\u00eb s\u00eb shumti preket gjinia mashkullore sesa ajo fem\u00ebrore. Simptomat e leukemis\u00eb kronike mieloide shpesh jan\u00eb t\u00eb paqarta dhe p\u00ebrfshijn\u00eb: rraskapitje, lodhje, djersitje nat\u00ebn, humbje t\u00eb pesh\u00ebs, ethe, dhimbje n\u00eb kocka, shpretk\u00eb e zmadhuar, dhimbje dhe ndjesi fryrje n\u00eb stomak.<\/p>\n<p>S\u00ebmundje m\u00eb s\u00eb shumti zbulohet n\u00eb faz\u00ebn kronike, kur gjat\u00eb nj\u00eb analize rutin\u00eb gjaku zbulohet niveli i rritur i qelizave t\u00eb bardha t\u00eb gjakut (WBC) ose kur zbulohet shpretka e zmadhuar gjat\u00eb nj\u00eb kontrolli t\u00eb p\u00ebrgjithsh\u00ebm fizik.<\/p>\n<p>Madh\u00ebsia normale e shpretk\u00ebs zakonisht nuk ndihet, por shpretka e zmadhuar mund t\u00eb zbulohet n\u00eb an\u00ebn e majt\u00eb t\u00eb pjes\u00ebs s\u00eb sip\u00ebrme t\u00eb stomakut, n\u00ebn cepin e brinj\u00ebs.<br \/>\nShpretka normalisht i depoziton qelizat e gjakut dhe i shkat\u00ebrron qelizat e vjetra t\u00eb gjakut. N\u00eb CML, shpretka mund t\u00eb zmadhohet p\u00ebr shkak t\u00eb qelizave shtes\u00eb t\u00eb bardha t\u00eb gjakut, q\u00eb e okupojn\u00eb organin.<br \/>\nSimptomat jospecifike , si lodhja dhe humbja e pesh\u00ebs, mundet q\u00eb t\u00eb shfaqen shum\u00eb m\u00eb von\u00eb, pas fillimit t\u00eb s\u00ebmundjes. Humbja e energjis\u00eb dhe aft\u00ebsit\u00eb e reduktuara p\u00ebr st\u00ebrvitje mund t\u00eb shfaqen n\u00eb faz\u00ebn kronike, pas disa muajsh.<br \/>\nLeukemia kronike mieloide shpesh diagnostifikohet me nj\u00eb test t\u00eb thjesht\u00eb gjaku. Rezultatet nga analiza mund t\u00eb tregojn\u00eb num\u00ebr jonormal t\u00eb lart\u00eb t\u00eb qelizave t\u00eb bardha t\u00eb gjakut, nga 50.000 deri n\u00eb 100.000 qeliza t\u00eb bardha gjaku n\u00eb mikrolit\u00ebr, nd\u00ebrsa vlera normale \u00ebsht\u00eb m\u00eb pak se 11.000.<\/p>\n<p>Analiza kromozonike e qelizave leucemike t\u00eb bardha t\u00eb gjakut thuajse gjithmon\u00eb tregon p\u00ebr nj\u00eb rishp\u00ebrndarje t\u00eb kromozomeve. Qelizat leukemike shpesh posedojn\u00eb kromozomin Filadelfia (kromozom q\u00eb ka pjes\u00ebz specifike nga nj\u00eb tjet\u00ebr kromozom i kapur tek ai), si edhe transformime jonormale t\u00eb tjera t\u00eb kromozomit.<\/p>\n<p>Cili \u00ebsht\u00eb shkaku p\u00ebr CML?<br \/>\nNdryshimet e caktuara n\u00eb ADN mund t\u00eb shkaktojn\u00eb q\u00eb qelizat normale t\u00eb palc\u00ebs s\u00eb kock\u00ebs t\u00eb shnd\u00ebrrohen n\u00eb qeliza t\u00eb leukemis\u00eb. Personat me CML e kan\u00eb n\u00eb p\u00ebrgjith\u00ebsi kromozomin Filadelfia , i cili e p\u00ebrmban gjenin anormal BCR-ABL. Ky gjen shkakton q\u00eb qelizat e bardha t\u00eb gjakut t\u00eb rriten anormale dhe pa kontroll, duke shkaktuar leukemin\u00eb.<\/p>\n<p>\u00cbsht\u00eb tipike q\u00eb s\u00ebmundja t\u00eb zhvillohet n\u00eb faza:<br \/>\nFaza kronike<br \/>\nKjo \u00ebsht\u00eb faza e par\u00eb e CML. N\u00eb k\u00ebt\u00eb faz\u00eb numri i qelizave t\u00eb bardha t\u00eb gjakut n\u00eb gjak dhe ose palc\u00ebn e kock\u00ebs tashm\u00eb \u00ebsht\u00eb rritur. N\u00eb k\u00ebt\u00eb faz\u00eb, m\u00eb pak se 10% t\u00eb qelizave n\u00eb gjak dhe palc\u00ebn e kock\u00ebs jan\u00eb qeliza blaste. Sistem imunitar ende vazhdon t\u00eb funksionoj\u00eb shum\u00eb mir\u00eb n\u00eb faz\u00ebn kronike, ashtu q\u00eb organizmi ka aft\u00ebsi q\u00eb t\u00eb luftoj\u00eb kund\u00ebr infeksioneve.<\/p>\n<p>Faza e avancuar<br \/>\nN\u00eb k\u00ebt\u00eb faz\u00eb, 10% deri n\u00eb 19% t\u00eb qelizave n\u00eb gjak dhe n\u00eb palc\u00ebn e kock\u00ebs jan\u00eb qeliza blaste. Kjo p\u00ebrqindje \u00ebsht\u00eb m\u00eb e lart\u00eb sesa n\u00eb faz\u00ebn kronike, nd\u00ebrsa qelizat e leukemis\u00eb rriten dhe shkaktojn\u00eb simptoma q\u00eb p\u00ebrfshijn\u00eb ethet, humbjen e pesh\u00ebs s\u00eb trupit, humbjen e oreksit dhe shpretk\u00ebn e zmadhuar.<\/p>\n<p>Faza blaste<br \/>\nKjo \u00ebsht\u00eb faza e tret\u00eb dhe e fundit dhe ka potencial q\u00eb t\u00eb beh\u00ebt e rreziksh\u00ebm p\u00ebr jet\u00ebn. Numri i qelizave blaste n\u00eb gjak dhe ose n\u00eb palc\u00ebn e kock\u00ebs b\u00ebhet shum\u00eb i lart\u00eb dhe k\u00ebto qeliza p\u00ebrhapen edhe n\u00eb inde t\u00eb tjera. N\u00eb rast se shfaqen: lodhje, ethe dhe zmadhim i shpretk\u00ebs gjat\u00eb periudh\u00ebs s\u00eb faz\u00ebs blaste, ajo b\u00ebhet kriz\u00eb blastike.<\/p>\n<p>Leucemia kronike mieloide (CML) \u00ebsht\u00eb s\u00ebmundje malinje hematologjike tek e cila \u00ebsht\u00eb arritur nj\u00eb p\u00ebrparim i madh sa i takon kurimit gjat\u00eb 20 viteve t\u00eb fundit. Fal\u00eb zbulimit t\u00eb terapis\u00eb specifike molekulare t\u00eb targetuar dhe ila\u00e7it \u201eImatinib\u201c, mbijetimi \u00ebsht\u00eb rritur s\u00eb tep\u00ebrmi si edhe cil\u00ebsia e jet\u00ebs p\u00ebr t\u00eb s\u00ebmur\u00ebt me CML n\u00eb bot\u00eb.<\/p>\n<p>Pacient\u00ebve me leukemi kronike mieloide (CML) nga Maqedonia, q\u00eb nuk reagojn\u00eb optimalisht me terapin\u00eb \u201eImatinib\u201d, iu mund\u00ebsua q\u00eb t\u00eb marrin medikamentin \u201eNilotinib\u201c, q\u00eb \u00ebsht\u00eb nj\u00eb medikament i ri specifik dhe m\u00eb superior.<br \/>\nMe k\u00ebt\u00eb preparat \u00ebsht\u00eb siguruar trajtim m\u00eb efikas i t\u00eb s\u00ebmur\u00ebve me CML, sidomos p\u00ebr ato q\u00eb nuk kan\u00eb p\u00ebrgjigje t\u00eb k\u00ebnaqshme terapeutike n\u00eb terapin\u00eb e linj\u00ebs s\u00eb par\u00eb me preparatin \u201eImatinib\u201c.<\/p>\n\n<div style=\"font-size: 0px; height: 0px; line-height: 0px; margin: 0; padding: 0; clear: both;\"><\/div>","protected":false},"excerpt":{"rendered":"<p>LEUCEMIA KRONIKE MIELOIDE MKB S 92.1 Chronic myeloid leukaemia (CML) Leukemia kronike mieloide (CML) \u00ebsht\u00eb s\u00ebmundje e ngadalt\u00eb progresive e [&hellip;]<\/p>\n","protected":false},"author":24,"featured_media":107594,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_mo_disable_npp":"","inline_featured_image":false},"categories":[1794],"tags":[],"imageURL":"https:\/\/sdk.mk\/wp-content\/uploads\/2020\/02\/25-Chronic-myeloid-leukaemia-CML-650x366.png","thumbURL":"https:\/\/sdk.mk\/wp-content\/uploads\/2020\/02\/25-Chronic-myeloid-leukaemia-CML-250x141.png","categoryNames":["Uncategorized"],"feature_caption":"","subtitle":"","views":"16041","source":"\u0421\u043a\u043e\u043f\u0458\u0435, (\u0421\u0410\u041a\u0410\u041c\u0414\u0410\u041a\u0410\u0416\u0410\u041c.\u041c\u041a)","yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v15.0 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>JU NJOFTOJM\u00cb ME S\u00cbMUNDJET E RRALLA: LEUKEMIA KRONIKE MIELOIDE - \u0421\u0430\u043a\u0430\u043c \u0414\u0430 \u041a\u0430\u0436\u0430\u043c<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/sdk.mk\/index.php\/uncategorized-sq\/ju-njoftojme-me-semundjet-e-rralla-leukemia-kronike-mieloide\/\" \/>\n<meta property=\"og:locale\" content=\"mk_MK\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"JU NJOFTOJM\u00cb ME S\u00cbMUNDJET E RRALLA: LEUKEMIA KRONIKE MIELOIDE - \u0421\u0430\u043a\u0430\u043c \u0414\u0430 \u041a\u0430\u0436\u0430\u043c\" \/>\n<meta property=\"og:description\" content=\"LEUCEMIA KRONIKE MIELOIDE MKB S 92.1 Chronic myeloid leukaemia (CML) Leukemia kronike mieloide (CML) \u00ebsht\u00eb s\u00ebmundje e ngadalt\u00eb progresive e [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/sdk.mk\/index.php\/uncategorized-sq\/ju-njoftojme-me-semundjet-e-rralla-leukemia-kronike-mieloide\/\" \/>\n<meta property=\"og:site_name\" content=\"\u0421\u0430\u043a\u0430\u043c \u0414\u0430 \u041a\u0430\u0436\u0430\u043c\" \/>\n<meta property=\"article:published_time\" content=\"2020-02-25T08:08:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/sdk.mk\/wp-content\/uploads\/2020\/02\/25-Chronic-myeloid-leukaemia-CML.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1080\" \/>\n<meta property=\"fb:app_id\" content=\"2407985809428537\" \/>\n<meta name=\"twitter:card\" content=\"summary\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebSite\",\"@id\":\"https:\/\/sdk.mk\/#website\",\"url\":\"https:\/\/sdk.mk\/\",\"name\":\"\\u0421\\u0430\\u043a\\u0430\\u043c \\u0414\\u0430 \\u041a\\u0430\\u0436\\u0430\\u043c\",\"description\":\"\\u0417\\u0430 \\u0441\\u043b\\u043e\\u0431\\u043e\\u0434\\u043e\\u0443\\u043c\\u043d\\u0438\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":\"https:\/\/sdk.mk\/?s={search_term_string}\",\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"mk-MK\"},{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/sdk.mk\/index.php\/uncategorized-sq\/ju-njoftojme-me-semundjet-e-rralla-leukemia-kronike-mieloide\/#primaryimage\",\"inLanguage\":\"mk-MK\",\"url\":\"https:\/\/sdk.mk\/wp-content\/uploads\/2020\/02\/25-Chronic-myeloid-leukaemia-CML.png\",\"width\":1920,\"height\":1080},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/sdk.mk\/index.php\/uncategorized-sq\/ju-njoftojme-me-semundjet-e-rralla-leukemia-kronike-mieloide\/#webpage\",\"url\":\"https:\/\/sdk.mk\/index.php\/uncategorized-sq\/ju-njoftojme-me-semundjet-e-rralla-leukemia-kronike-mieloide\/\",\"name\":\"JU NJOFTOJM\\u00cb ME S\\u00cbMUNDJET E RRALLA: LEUKEMIA KRONIKE MIELOIDE - \\u0421\\u0430\\u043a\\u0430\\u043c \\u0414\\u0430 \\u041a\\u0430\\u0436\\u0430\\u043c\",\"isPartOf\":{\"@id\":\"https:\/\/sdk.mk\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/sdk.mk\/index.php\/uncategorized-sq\/ju-njoftojme-me-semundjet-e-rralla-leukemia-kronike-mieloide\/#primaryimage\"},\"datePublished\":\"2020-02-25T08:08:54+00:00\",\"dateModified\":\"2020-02-25T08:08:54+00:00\",\"author\":{\"@id\":\"https:\/\/sdk.mk\/#\/schema\/person\/864d4cb4c82a45f771023b00a4aa5176\"},\"inLanguage\":\"mk-MK\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/sdk.mk\/index.php\/uncategorized-sq\/ju-njoftojme-me-semundjet-e-rralla-leukemia-kronike-mieloide\/\"]}]},{\"@type\":\"Person\",\"@id\":\"https:\/\/sdk.mk\/#\/schema\/person\/864d4cb4c82a45f771023b00a4aa5176\",\"name\":\"Biljana Nestoroska\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","_links":{"self":[{"href":"https:\/\/sdk.mk\/index.php\/wp-json\/wp\/v2\/posts\/107596"}],"collection":[{"href":"https:\/\/sdk.mk\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/sdk.mk\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/sdk.mk\/index.php\/wp-json\/wp\/v2\/users\/24"}],"replies":[{"embeddable":true,"href":"https:\/\/sdk.mk\/index.php\/wp-json\/wp\/v2\/comments?post=107596"}],"version-history":[{"count":0,"href":"https:\/\/sdk.mk\/index.php\/wp-json\/wp\/v2\/posts\/107596\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/sdk.mk\/index.php\/wp-json\/wp\/v2\/media\/107594"}],"wp:attachment":[{"href":"https:\/\/sdk.mk\/index.php\/wp-json\/wp\/v2\/media?parent=107596"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/sdk.mk\/index.php\/wp-json\/wp\/v2\/categories?post=107596"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/sdk.mk\/index.php\/wp-json\/wp\/v2\/tags?post=107596"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}